These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18637945)

  • 1. Huntington's disease: roles of huntingtin-interacting protein 1 (HIP-1) and its molecular partner HIPPI in the regulation of apoptosis and transcription.
    Bhattacharyya NP; Banerjee M; Majumder P
    FEBS J; 2008 Sep; 275(17):4271-9. PubMed ID: 18637945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of apoptosis in cells expressing exogenous Hippi, a molecular partner of huntingtin-interacting protein Hip1.
    Majumder P; Chattopadhyay B; Mazumder A; Das P; Bhattacharyya NP
    Neurobiol Dis; 2006 May; 22(2):242-56. PubMed ID: 16364650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BLOC1S2 interacts with the HIPPI protein and sensitizes NCH89 glioblastoma cells to apoptosis.
    Gdynia G; Lehmann-Koch J; Sieber S; Tagscherer KE; Fassl A; Zentgraf H; Matsuzawa S; Reed JC; Roth W
    Apoptosis; 2008 Mar; 13(3):437-47. PubMed ID: 18188704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal specificity of gene expression dysregulation in Huntington's disease.
    Thomas EA
    J Neurosci Res; 2006 Nov; 84(6):1151-64. PubMed ID: 16983659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rybp interacts with Hippi and enhances Hippi-mediated apoptosis.
    Stanton SE; Blanck JK; Locker J; Schreiber-Agus N
    Apoptosis; 2007 Dec; 12(12):2197-206. PubMed ID: 17874297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of HIPPI, a molecular partner of Huntingtin interacting protein HIP1, with the specific motif present at the putative promoter sequence of the caspase-1, caspase-8 and caspase-10 genes.
    Majumder P; Choudhury A; Banerjee M; Lahiri A; Bhattacharyya NP
    FEBS J; 2007 Aug; 274(15):3886-99. PubMed ID: 17623017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning, expression, purification, crystallization and preliminary crystallographic analysis of pseudo death-effector domain of HIPPI, a molecular partner of Huntingtin-interacting protein HIP-1.
    Banerjee M; Majumder P; Bhattacharyya NP; Dattagupta JK; Sen U
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Dec; 62(Pt 12):1247-50. PubMed ID: 17142908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of mitochondria in the pathogenesis of Huntington's disease].
    Karachitos A; Gałgańska H; Kmita H
    Postepy Biochem; 2010; 56(2):174-81. PubMed ID: 20873112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Huntington's disease: the current state of research with peripheral tissues.
    Sassone J; Colciago C; Cislaghi G; Silani V; Ciammola A
    Exp Neurol; 2009 Oct; 219(2):385-97. PubMed ID: 19460373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of disease: Histone modifications in Huntington's disease.
    Sadri-Vakili G; Cha JH
    Nat Clin Pract Neurol; 2006 Jun; 2(6):330-8. PubMed ID: 16932577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi.
    Gervais FG; Singaraja R; Xanthoudakis S; Gutekunst CA; Leavitt BR; Metzler M; Hackam AS; Tam J; Vaillancourt JP; Houtzager V; Rasper DM; Roy S; Hayden MR; Nicholson DW
    Nat Cell Biol; 2002 Feb; 4(2):95-105. PubMed ID: 11788820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of age at onset of Huntington disease patients by variations in TP53 and human caspase activated DNase (hCAD) genes.
    Chattopadhyay B; Baksi K; Mukhopadhyay S; Bhattacharyya NP
    Neurosci Lett; 2005 Feb; 374(2):81-6. PubMed ID: 15644269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondria and Huntington's disease pathogenesis: insight from genetic and chemical models.
    Browne SE
    Ann N Y Acad Sci; 2008 Dec; 1147():358-82. PubMed ID: 19076457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanisms of neuronal death in Huntington's disease. Second part: therapeutic challenges].
    Bantubungi K; Blum D
    Rev Med Brux; 2007; 28(6):487-94. PubMed ID: 18265808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure at 2.8 A of Huntingtin-interacting protein 1 (HIP1) coiled-coil domain reveals a charged surface suitable for HIP1 protein interactor (HIPPI).
    Niu Q; Ybe JA
    J Mol Biol; 2008 Feb; 375(5):1197-205. PubMed ID: 18155047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription regulation of caspase-1 by R393 of HIPPI and its molecular partner HIP-1.
    Banerjee M; Datta M; Majumder P; Mukhopadhyay D; Bhattacharyya NP
    Nucleic Acids Res; 2010 Jan; 38(3):878-92. PubMed ID: 19934260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathophysiology of Huntington's disease: an update].
    Roze E; Betuing S; Deyts C; Vidailhet M; Caboche J
    Rev Neurol (Paris); 2008 Dec; 164(12):977-94. PubMed ID: 18808762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of intracellular HAP1 trafficking.
    Rong J; Li SH; Li XJ
    J Neurosci Res; 2007 Nov; 85(14):3025-9. PubMed ID: 17474105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Huntington's disease-like syndromes: what to consider in patients with a negative Huntington's disease gene test.
    Schneider SA; Walker RH; Bhatia KP
    Nat Clin Pract Neurol; 2007 Sep; 3(9):517-25. PubMed ID: 17805246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of apoptosis and mitochondrial abnormalities in peripheral blood cells of Huntington's disease patients.
    Almeida S; Sarmento-Ribeiro AB; Januário C; Rego AC; Oliveira CR
    Biochem Biophys Res Commun; 2008 Oct; 374(4):599-603. PubMed ID: 18625199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.